tryptophan and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

tryptophan has been researched along with Chronic Inflammatory Demyelinating Polyradiculoneuropathy in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hahn, K; Harms, L; Klehmet, J; Lieker, I; Slowinski, T	1
Benzing, T; Burghaus, L; Dohmen, C; Fassbender, C; Fink, GR; Frischmuth, N; Galldiks, N; Haupt, WF; Hollinger, P; Klingel, R; Leebmann, J; Nazli, N; Pollok, M; Teschner, S	1
Burns, TM; Dimberg, EL; Klein, CJ; Phillips, LH; Vaught, BK	1

Trials

1 trial(s) available for tryptophan and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Article	Year
A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy. Journal of clinical apheresis, 2017, Volume: 32, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Blood Component Removal; Humans; Immunosorbent Techniques; Middle Aged; Pilot Projects; Plasma Exchange; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prospective Studies; Treatment Outcome; Tryptophan	2017

Article

Year

A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy.

Journal of clinical apheresis, 2017, Volume: 32, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Blood Component Removal; Humans; Immunosorbent Techniques; Middle Aged; Pilot Projects; Plasma Exchange; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prospective Studies; Treatment Outcome; Tryptophan

2017

Other Studies

2 other study(ies) available for tryptophan and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Article	Year
Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment. European neurology, 2011, Volume: 66, Issue:4 Topics: Aged; Disability Evaluation; Female; Humans; Immunosorbent Techniques; Longitudinal Studies; Male; Middle Aged; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Retrospective Studies; Treatment Outcome; Tryptophan	2011
Novel myelin protein zero mutation (Arg36Trp) in a patient with acute onset painful neuropathy. Neuromuscular disorders : NMD, 2006, Volume: 16, Issue:5 Topics: Acute Disease; Amino Acid Substitution; Arginine; Disease Progression; DNA Mutational Analysis; Genetic Predisposition to Disease; Genetic Testing; Hereditary Sensory and Motor Neuropathy; Humans; Inheritance Patterns; Male; Middle Aged; Myelin P0 Protein; Neuralgia; Peripheral Nerves; Peripheral Nervous System Diseases; Point Mutation; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Time Factors; Tryptophan	2006

Article

Year

Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment.

European neurology, 2011, Volume: 66, Issue:4

Topics: Aged; Disability Evaluation; Female; Humans; Immunosorbent Techniques; Longitudinal Studies; Male; Middle Aged; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Retrospective Studies; Treatment Outcome; Tryptophan

2011

Novel myelin protein zero mutation (Arg36Trp) in a patient with acute onset painful neuropathy.

Neuromuscular disorders : NMD, 2006, Volume: 16, Issue:5

Topics: Acute Disease; Amino Acid Substitution; Arginine; Disease Progression; DNA Mutational Analysis; Genetic Predisposition to Disease; Genetic Testing; Hereditary Sensory and Motor Neuropathy; Humans; Inheritance Patterns; Male; Middle Aged; Myelin P0 Protein; Neuralgia; Peripheral Nerves; Peripheral Nervous System Diseases; Point Mutation; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Time Factors; Tryptophan

2006